MUSTANG BIO, INC. — Director's Dealing 2023

Jul 7, 2023

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MUSTANG BIO, INC. (MBIO)
CIK: 0001680048
Period of Report: 2023-07-05

Reporting Person: Chill Adam J. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2023-07-05	COMMON STOCK, PAR VALUE $0.0001	A	7246	$0.0000	Acquired	19170	Direct

Footnotes

F1: The Reporting Person was granted 7,246 restricted shares pursuant to the Issuer's 2016 Incentive Plan on July 5, 2023. The shares will vest on July 5, 2026, subject to the Reporting Person's continued service on the Issuer's board on such date.

F2: Effective April 3, 2023, the Issuer effected a fifteen-for-one reverse stock split of its common stock (the "Reverse Stock Split"). The amount of common stock reflected on this Form 4 has been adjusted to reflect the Reverse Stock Split.

F3: Includes restricted share units, which vest over various time periods.